K8Q-66388-92076
3 vaccinations
1 coded response
35 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 492 / MI
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
-
2021-01-28
Survey response — day 14, dose 1MedDRA: Eye swelling, Headache, Lacrimation increased, Ocular hyperaemia — Feeling: GoodFree text: Thursday night- 1/21 developed a headache behind my left eye/eye socket. Eye turned red, eye lids swelled and eye became extremely watery. The next morning it was back to normal minus swelling.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Dose 2 — Pfizer-BioNTech
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-05-07
- 2021-08-05
-
2021-10-15
Dose 3 — Pfizer-BioNTech
- 2021-10-15
-
2021-10-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-18
- 2021-10-19
- 2021-10-22
- 2021-10-29
- 2021-11-07
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2022-01-14
- 2022-04-15
- 2022-10-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
Free text
Release 2 — day 14, dose 1
Symptoms: Thursday night- 1/21 developed a headache behind my left eye/eye socket. Eye turned red, eye lids swelled and eye became extremely watery. The next morning it was back to normal minus swelling.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eye swelling | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lacrimation increased | ✓ | ✓ | ✓ |
| SD | Ocular hyperaemia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release